Merck
MRK
#73
Rank
$198.52 B
Marketcap
$79.06
Share price
-0.29%
Change (1 day)
-39.52%
Change (1 year)

Merck (MRK) - Total liabilities

Total liabilities on the balance sheet as of March 2025 : $66.72 Billion USD

According to Merck's latest financial reports the company's total liabilities are $66.72 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Merck - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$70.73 B2.45%
2023-12-31$69.04 B9.41%
2022-12-31$63.10 B-6.43%
2021-12-31$67.43 B1.89%
2020-12-31$66.18 B13.34%
2019-12-31$58.39 B4.74%
2018-12-31$55.75 B4.6%
2017-12-31$53.30 B-3.21%
2016-12-31$55.06 B-3.23%
2015-12-31$56.91 B15.26%
2014-12-31$49.37 B-7.4%
2013-12-31$53.31 B5.23%
2012-12-31$50.66 B5.16%
2011-12-31$48.18 B-1.62%
2010-12-31$48.97 B-3.65%
2009-12-31$50.82 B95.28%
2008-12-31$26.02 B-6.23%
2007-12-31$27.75 B12.82%
2006-12-31$24.60 B0.59%
2005-12-31$24.46 B6.92%
2004-12-31$22.87 B8.45%
2003-12-31$21.09 B-13.66%
2002-12-31$24.43 B5.61%
2001-12-31$23.13 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
$117.39 B 75.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$115.56 B 73.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$73.54 B 10.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$74.97 B 12.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$62.20 B-6.76%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
$60.87 B-8.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
$32.14 B-51.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
$61.48 B-7.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
$32.38 B-51.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$83.16 B 24.64%๐Ÿ‡บ๐Ÿ‡ธ USA